James E Eichel, MD
Family Practice · Menlo Park
- Medicare standing
- 2 flags on the record
- Listed below.
- Plans that list them
- 9
- 1 carrier
- Offices
- 2
On the public record
- California licence: Accusation Filed
- 1 Medical Board action on record
Offices
2 locations · University Healthcare Alliance · 334 clinicians in this group
Looking this up.
Hospitals listed: 053137 · 058425 · 059546 · 557796 · Alameda Hospital · Alta Bates Summit Medical Center · Alta Bates Summit Medical Center - Alta Bates Camp · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Eichel’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G74264 · Current
Licensed to practise in California · since 1992 · expires 2028-03-31 · University of California, San Diego School of Medicine. Board flags: Accusation Filed.
Public record actions
| 2026-05-01 | Board disciplineDiscipline | Accusation filed. the physician has not had a hearing or been found guilty of any charges. · 8002024104663 |
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alameda HospitalAlameda, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency departmentPart of Alameda Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 64% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Alameda Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 4 the same, 0 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0 to 2.12) · 119 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.89 (0.45 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.9 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.3 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.5 · 210 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.7 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 532 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 1,887 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.04 to 0.47) · 1,916 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.37 (0.77 to 5.96) · 80 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.3 (0.58 to 4.02) · 85 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 38 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 1.23) · 1,359 cases | No different | Jul 2022 – Jun 2024 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 98 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -2.4 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -3.6 · 242 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 244 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 40 cases | None | Jul 2023 – Jun 2025 |
What patients said (319 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 69% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 65% |
| Nurses "always" listened carefully | 65% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 64% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$149,713
Medicare paid this office $149,713 for 388 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 221 | $33,831 | $153 |
| Return visit (30+ min) | 202 | $27,656 | $108 |
| Short return visit (20+ min) | 230 | $20,961 | $69 |
| Long return visit (40+ min) | 83 | $15,325 | $137 |
| Sarscov2 vac 50 mcg/0.5ml im | 78 | $12,259 | $146 |
See all 14 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 221 | $33,831 | $153 |
| Return visit (30+ min) | 202 | $27,656 | $108 |
| Short return visit (20+ min) | 230 | $20,961 | $69 |
| Long return visit (40+ min) | 83 | $15,325 | $137 |
| Sarscov2 vac 50 mcg/0.5ml im | 78 | $12,259 | $146 |
| Admn sarscov2 vacc 1 dose | 105 | $6,191 | $52 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 290 | $5,828 | $13 |
| Sarscv2 vac 30mcg trs-suc im | 36 | $5,403 | $150 |
| Influenza vaccine split virus, preservative free | 64 | $5,249 | $81 |
| Short return visit | 67 | $2,929 | $44 |
| Administration of influenza virus vaccine | 66 | $2,561 | $38 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 16 | $968 | $48 |
| Hemoglobin a1c level | 24 | $276 | $10 |
| Automated urinalysis test | 11 | $24 | $2 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of skin lesions | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
388 Original Medicare patients in 2024. Average age 76 · Under 65 6% · 85 and older 13% · Women 41% · Also on Medicaid 14% · Health risk score 1.13. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 62% · Depression 22% · Diabetes 19% · Coronary heart disease 17% · Chronic kidney disease 16% · Cancer 16% · Atrial fibrillation 15% · Heart failure 9% · COPD 8% · Dementia 7% · Stroke 7%.
The office billed $473,067, Medicare allowed $187,041 and paid $149,713; for 1,937 services of 40 kinds; $25,842 of it was for drugs given in the office and $123,871 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 388 | 1,937 | 76 | 1.13 | $473,067 | $149,713 |
| 2023 | 457 | 1,508 | 75 | 1.13 | $426,012 | $133,870 |
| 2022 | 537 | 1,775 | 74 | 1.07 | $520,021 | $166,592 |
| 2021 | 423 | 1,432 | 74 | 1.12 | $503,361 | $137,224 |
| 2020 | 372 | 1,438 | 74 | 1.25 | $457,060 | $104,382 |
| 2019 | 402 | 1,634 | 74 | 1.19 | $504,539 | $110,474 |
| 2018 | 317 | 1,375 | 74 | 1.19 | $414,325 | $98,543 |
| 2017 | 261 | 1,154 | 73 | 1.05 | $302,491 | $78,038 |
| 2016 | 226 | 891 | 73 | 1.04 | $216,210 | $54,513 |
| 2015 | 240 | 1,106 | 72 | 0.92 | $256,475 | $76,072 |
| 2014 | 252 | 965 | 72 | 1.08 | $213,022 | $60,045 |
| 2013 | 278 | 1,002 | 72 | 1.10 | $236,707 | $67,187 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 205 | $31,351 | $153 |
| Return visit (30+ min) | 205 | $25,402 | $97 |
| Short return visit (20+ min) | 212 | $18,086 | $67 |
| Long return visit (40+ min) | 102 | $18,078 | $143 |
| Influenza vaccine split virus, preservative free | 118 | $8,543 | $72 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 30 | $8,409 | $280 |
| Administration of influenza virus vaccine | 128 | $4,681 | $36 |
| Short return visit | 82 | $3,536 | $43 |
| Telephone medical discussion with physician, 21-30 minutes | 16 | $2,566 | $103 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 33 | $2,066 | $48 |
| Adm sarscv2 bvl 30mcg/.3ml a | 35 | $1,742 | $48 |
| Administration of pneumococcal vaccine | 30 | $1,089 | $36 |
| Hemoglobin a1c level | 17 | $181 | $10 |
| Automated urinalysis test | 13 | $29 | $2 |
2022: 16 services
| Return visit (30+ min) | 229 | $34,191 | $102 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 213 | $32,817 | $154 |
| Long return visit (40+ min) | 154 | $30,739 | $148 |
| Short return visit (20+ min) | 214 | $17,431 | $67 |
| Influenza vaccine split virus, preservative free | 173 | $11,912 | $68 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 37 | $10,322 | $279 |
| Administration of influenza virus vaccine | 187 | $6,781 | $36 |
| New patient visit (45+ min) | 20 | $3,231 | $162 |
| Telephone medical discussion with physician, 21-30 minutes | 21 | $2,949 | $98 |
| Short return visit | 58 | $2,531 | $44 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 34 | $2,276 | $48 |
| Administration of pneumococcal vaccine | 42 | $1,522 | $36 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 16 | $1,184 | $36 |
| Adm sarscv2 bvl 30mcg/.3ml a | 19 | $909 | $48 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 14 | $295 | $21 |
| Hemoglobin a1c level | 12 | $134 | $10 |
2021: 13 services
| Return visit (30+ min) | 251 | $39,887 | $100 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 188 | $29,915 | $159 |
| Long return visit (40+ min) | 101 | $21,897 | $162 |
| Short return visit (20+ min) | 194 | $18,333 | $72 |
| Telephone medical discussion with physician, 21-30 minutes | 44 | $6,251 | $101 |
| Influenza vaccine split virus, preservative free | 70 | $4,629 | $65 |
| Pneumococcal vaccine, 23-valent | 23 | $2,860 | $124 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 35 | $2,322 | $49 |
| Administration of influenza virus vaccine | 75 | $1,613 | $21 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | $1,561 | $74 |
| Short return visit | 27 | $925 | $33 |
| Administration of pneumococcal vaccine | 23 | $488 | $21 |
| Hemoglobin a1c level | 19 | $204 | $10 |
2020: 17 services
| Return visit (30+ min) | 207 | $29,451 | $84 |
| Short return visit (20+ min) | 222 | $18,159 | $53 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 119 | $16,762 | $141 |
| Telephone medical discussion with physician, 21-30 minutes | 67 | $10,861 | $93 |
| Influenza vaccine split virus, preservative free | 69 | $4,202 | $61 |
| Telephone medical discussion with physician, 11-20 minutes | 47 | $4,163 | $63 |
| Long return visit (40+ min) | 23 | $3,387 | $125 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 40 | $2,754 | $52 |
| Pneumococcal vaccine, 23-valent | 21 | $2,430 | $116 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 11 | $2,256 | $205 |
| Administration of influenza virus vaccine | 75 | $1,543 | $21 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 15 | $1,191 | $40 |
| Short return visit | 25 | $725 | $29 |
| New patient visit (30+ min) | 11 | $716 | $65 |
| Administration of pneumococcal vaccine | 27 | $549 | $20 |
| Hemoglobin a1c level | 14 | $145 | $10 |
| Removal of impacted ear wax by washing | 13 | $130 | $10 |
2019: 18 services
| Return visit (30+ min) | 239 | $37,910 | $87 |
| Short return visit (20+ min) | 226 | $22,255 | $57 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 80 | $11,170 | $140 |
| Influenza vaccine split virus, preservative free | 111 | $6,177 | $55 |
| Pneumococcal vaccine, 13-valent | 26 | $5,436 | $209 |
| Pneumococcal vaccine, 23-valent | 43 | $4,737 | $110 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 49 | $3,379 | $50 |
| Long return visit (40+ min) | 17 | $2,746 | $137 |
| New patient visit (30+ min) | 39 | $2,505 | $64 |
| Administration of influenza virus vaccine | 122 | $2,502 | $20 |
| New patient visit (45+ min) | 15 | $2,009 | $134 |
| Short return visit | 44 | $1,618 | $36 |
| Administration of pneumococcal vaccine | 69 | $1,392 | $20 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 17 | $1,082 | $39 |
| Hemoglobin a1c level | 20 | $222 | $11 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 11 | $205 | $19 |
| Removal of impacted ear wax by washing | 13 | $181 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $171 | $12 |
2018: 14 services
| Return visit (30+ min) | 220 | $39,945 | $86 |
| Short return visit (20+ min) | 182 | $19,811 | $56 |
| Pneumococcal vaccine, 13-valent | 37 | $7,291 | $197 |
| Pneumococcal vaccine, 23-valent | 44 | $4,646 | $106 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 33 | $4,564 | $138 |
| Long return visit (40+ min) | 32 | $4,370 | $121 |
| Influenza vaccine split virus, preservative free | 64 | $3,339 | $52 |
| New patient visit (30+ min) | 33 | $2,391 | $72 |
| Administration of pneumococcal vaccine | 80 | $2,023 | $25 |
| New patient visit (45+ min) | 17 | $1,969 | $116 |
| Administration of influenza virus vaccine | 71 | $1,821 | $25 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 26 | $1,482 | $49 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 20 | $276 | $14 |
| Removal of impacted ear wax by washing | 16 | $214 | $11 |
2017: 11 services
| Return visit (30+ min) | 178 | $32,254 | $84 |
| Short return visit (20+ min) | 155 | $17,786 | $55 |
| Pneumococcal vaccine, 13-valent | 32 | $5,985 | $187 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 37 | $4,969 | $134 |
| Influenza vaccine split virus, preservative free | 74 | $3,669 | $48 |
| Administration of influenza virus vaccine | 83 | $2,675 | $31 |
| New patient visit (30+ min) | 20 | $1,463 | $73 |
| Administration of pneumococcal vaccine | 43 | $1,337 | $31 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 24 | $1,296 | $50 |
| Pneumococcal vaccine, 23-valent | 11 | $1,057 | $96 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $191 | $14 |
2016: 9 services
| Return visit (30+ min) | 138 | $22,663 | $74 |
| Short return visit (20+ min) | 151 | $13,607 | $49 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 24 | $3,016 | $126 |
| Pneumococcal vaccine, 13-valent | 16 | $2,800 | $175 |
| Influenza vaccine split virus, preservative free | 62 | $2,387 | $38 |
| Administration of influenza virus vaccine | 68 | $2,074 | $30 |
| New patient visit (30+ min) | 22 | $1,319 | $60 |
| Long return visit (40+ min) | 11 | $1,297 | $118 |
| Administration of pneumococcal vaccine | 16 | $489 | $31 |
2015: 10 services
| Return visit (30+ min) | 156 | $27,778 | $77 |
| Pneumococcal vaccine, 13-valent | 106 | $16,953 | $158 |
| Short return visit (20+ min) | 127 | $11,139 | $52 |
| Administration of pneumococcal vaccine | 101 | $3,231 | $32 |
| Influenza vaccine split virus, preservative free | 81 | $2,896 | $35 |
| Administration of influenza virus vaccine | 83 | $2,702 | $32 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 17 | $2,165 | $127 |
| Long return visit (40+ min) | 21 | $2,053 | $98 |
| New patient visit (30+ min) | 22 | $1,909 | $87 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 11 | $475 | $37 |
2014: 8 services
| Return visit (30+ min) | 165 | $28,190 | $83 |
| Short return visit (20+ min) | 150 | $14,428 | $50 |
| Administration of influenza virus vaccine | 85 | $2,707 | $31 |
| Influenza vaccine split virus, preservative free | 78 | $2,604 | $33 |
| Long return visit (40+ min) | 15 | $1,935 | $114 |
| New patient visit (30+ min) | 20 | $1,247 | $62 |
| Pneumococcal vaccine, 23-valent | 17 | $1,243 | $73 |
| Administration of pneumococcal vaccine | 17 | $529 | $31 |
2013: 9 services
| Short return visit (20+ min) | 190 | $27,714 | $60 |
| Return visit (30+ min) | 150 | $22,971 | $90 |
| New patient visit (30+ min) | 31 | $2,688 | $87 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 13 | $2,474 | $190 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 18 | $2,299 | $128 |
| Administration of influenza virus vaccine | 67 | $2,153 | $32 |
| Influenza vaccine split virus, preservative free | 52 | $1,620 | $31 |
| Influenza vaccine, quadrivalent for nasal administration | 15 | $362 | $24 |
| Short return visit | 11 | $360 | $33 |
Medicaid work
$27,268 in 2024
Medicaid paid $27,268 for 621 billed services this clinician did in 2024, up to 39 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 319 | $15,992 |
| Short return visit (20+ min) | 274 | $10,764 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 13 | $394 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 15 | $118 |
| 2024 | 621 | 4 | 39 | $27,268 |
| 2023 | 818 | 4 | 49 | $32,098 |
| 2022 | 769 | 5 | 48 | $28,884 |
| 2021 | 928 | 5 | 47 | $32,343 |
| 2020 | 844 | 4 | 52 | $29,691 |
| 2019 | 195 | 3 | 33 | $7,419 |
| 2018 | 140 | 5 | 21 | $3,888 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 484 | $22,323 |
| Short return visit (20+ min) | 300 | $9,157 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 18 | $529 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 16 | $89 |
2022
| Return visit (30+ min) | 433 | $20,170 |
| Short return visit (20+ min) | 237 | $7,022 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 41 | $1,181 |
| Short return visit | 12 | $272 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 46 | $240 |
2021
| Return visit (30+ min) | 465 | $20,598 |
| Short return visit (20+ min) | 398 | $11,156 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 29 | $361 |
| Short return visit | 12 | $183 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 24 | $45 |
2020
| Return visit (30+ min) | 405 | $18,080 |
| Short return visit (20+ min) | 358 | $10,498 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 39 | $907 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 42 | $206 |
2019
| Return visit (30+ min) | 146 | $6,153 |
| Short return visit (20+ min) | 37 | $1,004 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 12 | $263 |
2018
| Return visit (30+ min) | 62 | $2,129 |
| Long return visit (40+ min) | 12 | $686 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 29 | $638 |
| Short return visit (20+ min) | 12 | $328 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 25 | $107 |
Drugs they prescribed that Part D paid
$312,742
Pharmacies billed $312,742 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 21% of their Part D prescriptions (434 of 2,089) in 2024. A higher opioid share than 9 in 10 peers; the typical family practice clinician is at 2%. Long-acting opioids: 17% of their opioid prescriptions.
1,802 generic and fewer than 11 brand-name prescriptions · $312,742 in drug cost · 34 antibiotic prescriptions to 23 people · 13 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Oxycontin | 23 | $49,761 | $2,164 |
| Rybelsus | 19 | $34,789 | $1,831 |
| Farxiga | 31 | $30,555 | $986 |
| Jardiance | 18 | $24,421 | $1,357 |
| Ozempic | 14 | $23,853 | $1,704 |
See all 58 drugs
| Oxycontin | 23 | $49,761 | $2,164 |
| Rybelsus | 19 | $34,789 | $1,831 |
| Farxiga | 31 | $30,555 | $986 |
| Jardiance | 18 | $24,421 | $1,357 |
| Ozempic | 14 | $23,853 | $1,704 |
| Trulicity | 19 | $20,675 | $1,088 |
| Eliquis | 13 | $18,360 | $1,412 |
| Testosterone | 11 | $5,747 | $522 |
| Hydrocodone-Acetaminophen | 151 | $4,353 | $29 |
| Fentanyl | 23 | $3,427 | $149 |
| Bupropion Xl | 15 | $2,342 | $156 |
| Morphine Sulfate Er | 25 | $1,698 | $68 |
| Estradiol | 11 | $1,593 | $145 |
| Gabapentin | 43 | $1,405 | $33 |
| Mirtazapine | 17 | $1,192 | $70 |
| Lantus Solostar | 11 | $1,035 | $94 |
| Dextroamphetamine-Amphetamine | 12 | $915 | $76 |
| Ezetimibe | 20 | $763 | $38 |
| Atorvastatin | 83 | $737 | $9 |
| Rosuvastatin | 55 | $675 | $12 |
| Tramadol | 113 | $618 | $5 |
| Levothyroxine | 43 | $618 | $14 |
| Valsartan | 21 | $561 | $27 |
| Diazepam | 91 | $556 | $6 |
| Memantine | 12 | $553 | $46 |
| Oxycodone | 29 | $476 | $16 |
| Ipratropium | 16 | $462 | $29 |
| Tamsulosin | 22 | $411 | $19 |
| Clonazepam | 24 | $376 | $16 |
| Alprazolam | 58 | $373 | $6 |
| Pregabalin | 12 | $363 | $30 |
| Potassium Chloride | 14 | $356 | $25 |
| Mometasone Furoate | 13 | $349 | $27 |
| Acetaminophen-Codeine | 23 | $348 | $15 |
| Albuterol Sulfate Hfa | 13 | $342 | $26 |
| Metformin Hcl Er | 26 | $327 | $13 |
| Lisinopril | 38 | $306 | $8 |
| Pantoprazole | 17 | $268 | $16 |
| Metoprolol | 23 | $268 | $12 |
| Oxycodone-Acetaminophen | 23 | $239 | $10 |
| Zolpidem | 39 | $237 | $6 |
| Olmesartan Medoxomil | 14 | $235 | $17 |
| Omeprazole | 15 | $211 | $14 |
| Lorazepam | 39 | $181 | $5 |
| Trazodone | 15 | $179 | $12 |
| Amlodipine Besylate | 45 | $167 | $4 |
| Famotidine | 15 | $154 | $10 |
| Hydrochlorothiazide | 28 | $144 | $5 |
| Hydralazine | 16 | $141 | $9 |
| Venlafaxine Hcl Er | 13 | $135 | $10 |
| Hydromorphone | 13 | $134 | $10 |
| Escitalopram | 17 | $124 | $7 |
| Spironolactone | 11 | $106 | $10 |
| Furosemide | 13 | $102 | $8 |
| Triamcinolone Acetonide | 15 | $98 | $7 |
| Donepezil | 11 | $97 | $9 |
| Metformin | 18 | $69 | $4 |
| Losartan | 15 | $64 | $4 |
Year by year
| 2024 | 2,089 | 352 | 21% (434) | None | $312,742 |
| 2023 | 2,214 | 379 | 18% (391) | 12% | $316,722 |
| 2022 | 2,134 | 347 | 13% (269) | 11% | $266,705 |
| 2021 | 2,165 | 369 | 13% (291) | None | $259,540 |
| 2020 | 2,158 | 363 | 11% (230) | None | $173,796 |
| 2019 | 2,367 | 370 | 9% (205) | 11% | $182,937 |
| 2018 | 2,153 | 343 | 5% (113) | 15% | $194,718 |
| 2017 | 2,302 | 296 | 4% (92) | 17% | $167,726 |
| 2016 | 3,216 | 373 | 6% (197) | 20% | $275,797 |
| 2015 | 3,826 | 387 | 5% (202) | 18% | $269,361 |
| 2014 | 5,506 | 390 | 4% (239) | 20% | $338,828 |
| 2013 | 5,274 | 340 | 5% (259) | 23% | $354,728 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 53 drugs
| Oxycontin | 29 | $60,986 | $2,103 |
| Farxiga | 32 | $44,167 | $1,380 |
| Eliquis | 16 | $17,203 | $1,075 |
| Rybelsus | 15 | $16,140 | $1,076 |
| Jardiance | 11 | $12,437 | $1,131 |
| Trulicity | 11 | $10,648 | $968 |
| Testosterone | 16 | $7,104 | $444 |
| Symbicort | 14 | $5,423 | $387 |
| Hydrocodone-Acetaminophen | 131 | $4,450 | $34 |
| Fentanyl | 22 | $3,564 | $162 |
| Rosuvastatin | 81 | $2,843 | $35 |
| Risedronate | 15 | $2,218 | $148 |
| Atorvastatin | 92 | $1,392 | $15 |
| Gabapentin | 22 | $1,307 | $59 |
| Tamsulosin | 30 | $1,172 | $39 |
| Pregabalin | 25 | $865 | $35 |
| Morphine Sulfate Er | 22 | $823 | $37 |
| Amlodipine Besylate | 58 | $734 | $13 |
| Dextroamphetamine-Amphetamine | 12 | $697 | $58 |
| Levothyroxine | 38 | $634 | $17 |
| Metoprolol | 39 | $624 | $16 |
| Diclofenac | 17 | $567 | $33 |
| Tramadol | 117 | $545 | $5 |
| Losartan | 32 | $508 | $16 |
| Alprazolam | 78 | $491 | $6 |
| Venlafaxine Hcl Er | 16 | $483 | $30 |
| Acetaminophen-Codeine | 20 | $452 | $23 |
| Diazepam | 78 | $437 | $6 |
| Lisinopril | 37 | $418 | $11 |
| Donepezil | 18 | $416 | $23 |
| Clonazepam | 36 | $411 | $11 |
| Zolpidem | 32 | $392 | $12 |
| Pravastatin | 20 | $377 | $19 |
| Metformin Hcl Er | 20 | $359 | $18 |
| Ezetimibe | 18 | $349 | $19 |
| Lorazepam | 58 | $318 | $5 |
| Valsartan | 11 | $298 | $27 |
| Olmesartan Medoxomil | 15 | $298 | $20 |
| Hydrochlorothiazide | 32 | $259 | $8 |
| Simvastatin | 13 | $246 | $19 |
| Hydralazine | 14 | $232 | $17 |
| Alendronate | 14 | $223 | $16 |
| Oxycodone | 24 | $200 | $8 |
| Potassium Chloride | 13 | $199 | $15 |
| Escitalopram | 15 | $186 | $12 |
| Famotidine | 14 | $183 | $13 |
| Pantoprazole | 13 | $169 | $13 |
| Quetiapine | 11 | $164 | $15 |
| Cyclobenzaprine | 13 | $160 | $12 |
| Hydromorphone | 14 | $153 | $11 |
| Metformin | 16 | $146 | $9 |
| Metoprolol | 11 | $112 | $10 |
| Triamcinolone Acetonide | 17 | $91 | $5 |
2022: 53 drugs
| Oxycontin | 17 | $34,780 | $2,046 |
| Eliquis | 23 | $27,880 | $1,212 |
| Rybelsus | 18 | $26,413 | $1,467 |
| Trulicity | 27 | $24,947 | $924 |
| Farxiga | 23 | $22,428 | $975 |
| Testosterone | 16 | $8,072 | $505 |
| Risedronate | 23 | $4,707 | $205 |
| Hydrocodone-Acetaminophen | 113 | $4,128 | $37 |
| Donepezil | 17 | $1,848 | $109 |
| Morphine Sulfate Er | 24 | $1,730 | $72 |
| Rosuvastatin | 66 | $1,637 | $25 |
| Memantine | 12 | $1,336 | $111 |
| Bumetanide | 14 | $1,215 | $87 |
| Atorvastatin | 96 | $994 | $10 |
| Metoprolol | 36 | $975 | $27 |
| Gabapentin | 42 | $940 | $22 |
| Levothyroxine | 48 | $890 | $19 |
| Valsartan | 17 | $840 | $49 |
| Losartan | 43 | $718 | $17 |
| Acetaminophen-Codeine | 25 | $645 | $26 |
| Alprazolam | 58 | $607 | $10 |
| Olmesartan Medoxomil | 24 | $587 | $24 |
| Lisinopril | 58 | $578 | $10 |
| Hydromorphone | 11 | $564 | $51 |
| Spironolactone-Hctz | 12 | $558 | $47 |
| Amlodipine Besylate | 67 | $439 | $7 |
| Tamsulosin | 15 | $420 | $28 |
| Escitalopram | 31 | $377 | $12 |
| Lorazepam | 53 | $358 | $7 |
| Diclofenac | 11 | $356 | $32 |
| Omeprazole | 27 | $345 | $13 |
| Baclofen | 11 | $342 | $31 |
| Bupropion | 16 | $327 | $20 |
| Clonazepam | 33 | $324 | $10 |
| Tramadol | 60 | $320 | $5 |
| Diazepam | 51 | $319 | $6 |
| Pravastatin | 13 | $305 | $23 |
| Famotidine | 14 | $296 | $21 |
| Hydralazine | 11 | $280 | $25 |
| Hydrochlorothiazide | 38 | $278 | $7 |
| Pantoprazole | 19 | $264 | $14 |
| Metformin Hcl Er | 19 | $225 | $12 |
| Cyclobenzaprine | 13 | $205 | $16 |
| Metoprolol | 38 | $203 | $5 |
| Metformin | 23 | $186 | $8 |
| Venlafaxine Hcl Er | 11 | $166 | $15 |
| Risperidone | 12 | $164 | $14 |
| Spironolactone | 12 | $163 | $14 |
| Zolpidem | 32 | $163 | $5 |
| Triamcinolone Acetonide | 24 | $161 | $7 |
| Montelukast | 12 | $149 | $12 |
| Fluticasone Propionate | 11 | $107 | $10 |
| Prednisone | 15 | $106 | $7 |
2021: 52 drugs
| Oxycontin | 23 | $37,805 | $1,644 |
| Trulicity | 24 | $31,869 | $1,328 |
| Farxiga | 31 | $29,556 | $953 |
| Eliquis | 15 | $14,085 | $939 |
| Jardiance | 18 | $13,005 | $722 |
| Testosterone | 14 | $8,682 | $620 |
| Risedronate | 22 | $5,704 | $259 |
| Hydrocodone-Acetaminophen | 139 | $3,819 | $27 |
| Atorvastatin | 145 | $2,243 | $15 |
| Morphine Sulfate Er | 19 | $1,267 | $67 |
| Memantine | 18 | $1,081 | $60 |
| Amlodipine Besylate | 106 | $1,015 | $10 |
| Levothyroxine | 49 | $999 | $20 |
| Valsartan | 24 | $969 | $40 |
| Losartan | 61 | $952 | $16 |
| Donepezil | 13 | $916 | $70 |
| Metoprolol | 33 | $900 | $27 |
| Gabapentin | 33 | $823 | $25 |
| Rosuvastatin | 35 | $793 | $23 |
| Alprazolam | 47 | $693 | $15 |
| Hydrochlorothiazide | 61 | $581 | $10 |
| Ezetimibe | 13 | $580 | $45 |
| Tamsulosin | 21 | $513 | $24 |
| Oxycodone-Acetaminophen | 11 | $477 | $43 |
| Hydromorphone | 16 | $448 | $28 |
| Hydralazine | 20 | $436 | $22 |
| Metformin | 46 | $399 | $9 |
| Pravastatin | 18 | $364 | $20 |
| Acetaminophen-Codeine | 18 | $348 | $19 |
| Lisinopril | 42 | $306 | $7 |
| Pantoprazole | 14 | $277 | $20 |
| Olmesartan Medoxomil | 14 | $274 | $20 |
| Tramadol | 48 | $256 | $5 |
| Zolpidem | 43 | $254 | $6 |
| Famotidine | 15 | $252 | $17 |
| Diazepam | 41 | $242 | $6 |
| Risperidone | 15 | $233 | $16 |
| Ramipril | 18 | $232 | $13 |
| Metformin Hcl Er | 19 | $229 | $12 |
| Trazodone | 12 | $217 | $18 |
| Omeprazole | 21 | $214 | $10 |
| Clonazepam | 31 | $207 | $7 |
| Lorazepam | 33 | $197 | $6 |
| Metoprolol | 21 | $184 | $9 |
| Sertraline | 16 | $183 | $11 |
| Felodipine Er | 12 | $155 | $13 |
| Escitalopram | 19 | $150 | $8 |
| Simvastatin | 19 | $135 | $7 |
| Clopidogrel | 13 | $133 | $10 |
| Chlorthalidone | 14 | $126 | $9 |
| Ibuprofen | 12 | $61 | $5 |
| Triamcinolone Acetonide | 12 | $60 | $5 |
2020: 47 drugs
| Oxycontin | 15 | $19,316 | $1,288 |
| Lantus Solostar | 16 | $8,290 | $518 |
| Breo Ellipta | 16 | $5,690 | $356 |
| Hydrocodone-Acetaminophen | 115 | $3,365 | $29 |
| Ibandronate | 34 | $2,945 | $87 |
| Atorvastatin | 126 | $1,823 | $14 |
| Levothyroxine | 73 | $1,763 | $24 |
| Spironolactone-Hctz | 15 | $1,621 | $108 |
| Metoprolol | 44 | $1,431 | $33 |
| Rosuvastatin | 27 | $1,425 | $53 |
| Losartan-Hydrochlorothiazide | 12 | $1,141 | $95 |
| Gabapentin | 45 | $1,122 | $25 |
| Losartan | 79 | $1,089 | $14 |
| Proair Hfa | 11 | $1,064 | $97 |
| Valsartan | 21 | $1,031 | $49 |
| Morphine Sulfate Er | 18 | $987 | $55 |
| Hydralazine | 21 | $790 | $38 |
| Amlodipine Besylate | 119 | $776 | $7 |
| Tamsulosin | 29 | $739 | $25 |
| Alprazolam | 52 | $683 | $13 |
| Diclofenac | 14 | $637 | $45 |
| Hydrochlorothiazide | 71 | $620 | $9 |
| Memantine | 11 | $586 | $53 |
| Pravastatin | 28 | $388 | $14 |
| Metformin | 45 | $379 | $8 |
| Omeprazole | 27 | $364 | $13 |
| Felodipine Er | 11 | $362 | $33 |
| Metformin Hcl Er | 23 | $346 | $15 |
| Acetaminophen-Codeine | 19 | $333 | $18 |
| Lisinopril | 48 | $333 | $7 |
| Allopurinol | 11 | $270 | $25 |
| Diazepam | 40 | $269 | $7 |
| Tramadol | 31 | $268 | $9 |
| Ramipril | 17 | $257 | $15 |
| Risperidone | 16 | $255 | $16 |
| Zolpidem | 37 | $251 | $7 |
| Sertraline | 16 | $240 | $15 |
| Simvastatin | 27 | $238 | $9 |
| Prednisone | 20 | $220 | $11 |
| Triamcinolone Acetonide | 17 | $151 | $9 |
| Clonazepam | 17 | $142 | $8 |
| Lorazepam | 31 | $109 | $4 |
| Furosemide | 11 | $103 | $9 |
| Alendronate | 11 | $92 | $8 |
| Spironolactone | 11 | $58 | $5 |
| Meloxicam | 13 | $56 | $4 |
| Cephalexin | 11 | $47 | $4 |
2019: 55 drugs
| Xarelto | 12 | $10,575 | $881 |
| Invokana | 15 | $8,841 | $589 |
| Lantus Solostar | 14 | $8,482 | $606 |
| Hydrocodone-Acetaminophen | 104 | $2,870 | $28 |
| Atorvastatin | 145 | $2,588 | $18 |
| Ibandronate | 26 | $2,215 | $85 |
| Memantine | 22 | $2,037 | $93 |
| Levothyroxine | 71 | $1,557 | $22 |
| Olmesartan Medoxomil | 19 | $1,341 | $71 |
| Metoprolol | 33 | $1,254 | $38 |
| Gabapentin | 41 | $1,109 | $27 |
| Spironolactone-Hctz | 15 | $1,035 | $69 |
| Amlodipine Besylate | 152 | $1,035 | $7 |
| Losartan | 83 | $882 | $11 |
| Sumatriptan | 18 | $703 | $39 |
| Hydralazine | 24 | $634 | $26 |
| Potassium Chloride | 18 | $625 | $35 |
| Temazepam | 11 | $609 | $55 |
| Mirtazapine | 12 | $578 | $48 |
| Allopurinol | 19 | $576 | $30 |
| Felodipine Er | 11 | $570 | $52 |
| Hydrochlorothiazide | 75 | $519 | $7 |
| Fluticasone Propionate | 16 | $502 | $31 |
| Diclofenac | 12 | $491 | $41 |
| Chlorthalidone | 12 | $451 | $38 |
| Pantoprazole | 12 | $427 | $36 |
| Pravastatin | 22 | $426 | $19 |
| Tamsulosin | 25 | $400 | $16 |
| Metformin | 46 | $379 | $8 |
| Lisinopril | 46 | $369 | $8 |
| Escitalopram | 21 | $357 | $17 |
| Omeprazole | 28 | $332 | $12 |
| Ramipril | 19 | $329 | $17 |
| Fluoxetine | 16 | $310 | $19 |
| Finasteride | 14 | $286 | $20 |
| Clopidogrel | 11 | $272 | $25 |
| Alprazolam | 42 | $267 | $6 |
| Carvedilol | 12 | $251 | $21 |
| Prednisone | 24 | $242 | $10 |
| Tramadol | 45 | $224 | $5 |
| Metformin Hcl Er | 26 | $216 | $8 |
| Zolpidem | 37 | $212 | $6 |
| Simvastatin | 20 | $199 | $10 |
| Methimazole | 13 | $192 | $15 |
| Sertraline | 18 | $178 | $10 |
| Triamcinolone Acetonide | 26 | $170 | $7 |
| Diazepam | 35 | $142 | $4 |
| Metoprolol | 17 | $130 | $8 |
| Losartan-Hydrochlorothiazide | 13 | $113 | $9 |
| Lorazepam | 27 | $108 | $4 |
| Acetaminophen-Codeine | 13 | $94 | $7 |
| Meloxicam | 22 | $87 | $4 |
| Clonazepam | 16 | $68 | $4 |
| Spironolactone | 12 | $50 | $4 |
| Furosemide | 11 | $43 | $4 |
2018: 54 drugs
| Advair Diskus | 21 | $13,048 | $621 |
| Xarelto | 17 | $12,570 | $739 |
| Lantus Solostar | 18 | $10,132 | $563 |
| Januvia | 16 | $7,836 | $490 |
| Spiriva | 17 | $7,459 | $439 |
| Novolog Flexpen | 12 | $6,458 | $538 |
| Atorvastatin | 91 | $1,640 | $18 |
| Carbidopa-Levodopa Er | 13 | $1,626 | $125 |
| Levothyroxine | 70 | $1,507 | $22 |
| Clonidine | 14 | $1,495 | $107 |
| Memantine | 19 | $1,475 | $78 |
| Metoprolol | 48 | $1,311 | $27 |
| Ibandronate | 25 | $1,295 | $52 |
| Ventolin Hfa | 13 | $1,187 | $91 |
| Hydrocodone-Acetaminophen | 59 | $1,158 | $20 |
| Amlodipine Besylate | 150 | $1,021 | $7 |
| Chlorthalidone | 18 | $827 | $46 |
| Gabapentin | 40 | $794 | $20 |
| Diclofenac | 15 | $776 | $52 |
| Losartan | 98 | $754 | $8 |
| Allopurinol | 32 | $738 | $23 |
| Felodipine Er | 11 | $714 | $65 |
| Hydralazine | 33 | $676 | $20 |
| Tamsulosin | 22 | $552 | $25 |
| Ramipril | 22 | $490 | $22 |
| Fluocinonide | 14 | $455 | $33 |
| Hydrochlorothiazide | 59 | $422 | $7 |
| Escitalopram | 26 | $411 | $16 |
| Metformin | 47 | $384 | $8 |
| Pantoprazole | 17 | $370 | $22 |
| Prednisone | 30 | $358 | $12 |
| Lisinopril | 46 | $351 | $8 |
| Potassium Chloride | 16 | $348 | $22 |
| Duloxetine | 11 | $344 | $31 |
| Zolpidem | 16 | $313 | $20 |
| Warfarin | 15 | $304 | $20 |
| Clopidogrel | 19 | $266 | $14 |
| Valsartan | 12 | $256 | $21 |
| Nitroglycerin | 12 | $241 | $20 |
| Methimazole | 14 | $238 | $17 |
| Pravastatin | 11 | $203 | $18 |
| Fluticasone Propionate | 12 | $184 | $15 |
| Simvastatin | 23 | $164 | $7 |
| Metformin Hcl Er | 19 | $155 | $8 |
| Alprazolam | 24 | $147 | $6 |
| Diazepam | 21 | $145 | $7 |
| Donepezil | 12 | $143 | $12 |
| Tramadol | 30 | $137 | $5 |
| Triamcinolone Acetonide | 14 | $132 | $9 |
| Furosemide | 19 | $91 | $5 |
| Buspirone | 11 | $63 | $6 |
| Sotalol | 11 | $42 | $4 |
| Lorazepam | 16 | $36 | $2 |
| Clonazepam | 11 | $34 | $3 |
2017: 58 drugs
| Januvia | 15 | $9,774 | $652 |
| Lantus Solostar | 17 | $9,070 | $534 |
| Invokana | 18 | $8,479 | $471 |
| Xarelto | 14 | $7,445 | $532 |
| Novolog Flexpen | 14 | $7,426 | $530 |
| Advair Diskus | 11 | $4,598 | $418 |
| Atorvastatin | 145 | $2,936 | $20 |
| Metformin Hcl Er | 36 | $2,476 | $69 |
| Levothyroxine | 82 | $2,190 | $27 |
| Clonidine | 12 | $1,982 | $165 |
| Metoprolol | 61 | $1,797 | $29 |
| Ibandronate | 16 | $1,439 | $90 |
| Diclofenac | 19 | $1,241 | $65 |
| Carbidopa-Levodopa Er | 11 | $1,199 | $109 |
| Proair Hfa | 13 | $963 | $74 |
| Gabapentin | 26 | $909 | $35 |
| Celecoxib | 15 | $908 | $61 |
| Valsartan | 22 | $849 | $39 |
| Amlodipine Besylate | 154 | $813 | $5 |
| Hydralazine | 37 | $762 | $21 |
| Tamsulosin | 26 | $725 | $28 |
| Felodipine Er | 12 | $722 | $60 |
| Hydrochlorothiazide | 88 | $658 | $7 |
| Losartan | 72 | $644 | $9 |
| Allopurinol | 17 | $634 | $37 |
| Chlorthalidone | 17 | $604 | $36 |
| Pravastatin | 15 | $553 | $37 |
| Simvastatin | 67 | $526 | $8 |
| Potassium Chloride | 13 | $511 | $39 |
| Metformin | 66 | $493 | $7 |
| Escitalopram | 44 | $490 | $11 |
| Klor-Con 10 | 13 | $482 | $37 |
| Memantine | 12 | $428 | $36 |
| Ramipril | 29 | $395 | $14 |
| Hydrocodone-Acetaminophen | 39 | $384 | $10 |
| Lisinopril | 82 | $368 | $4 |
| Montelukast | 23 | $320 | $14 |
| Omeprazole | 19 | $306 | $16 |
| Warfarin | 14 | $260 | $19 |
| Carvedilol | 29 | $225 | $8 |
| Mometasone Furoate | 11 | $223 | $20 |
| Fluticasone Propionate | 14 | $195 | $14 |
| Alendronate | 26 | $194 | $7 |
| Tramadol | 34 | $192 | $6 |
| Triamcinolone Acetonide | 23 | $146 | $6 |
| Losartan-Hydrochlorothiazide | 17 | $122 | $7 |
| Diazepam | 15 | $114 | $8 |
| Zolpidem | 17 | $107 | $6 |
| Acetaminophen-Codeine | 11 | $102 | $9 |
| Ranitidine | 20 | $95 | $5 |
| Spironolactone | 11 | $88 | $8 |
| Sertraline | 21 | $86 | $4 |
| Buspirone | 15 | $85 | $6 |
| Furosemide | 14 | $84 | $6 |
| Alprazolam | 15 | $68 | $5 |
| Atenolol | 14 | $67 | $5 |
| Metoprolol | 13 | $54 | $4 |
| Trazodone | 11 | $51 | $5 |
2016: 79 drugs
| Metformin Hcl Er | 35 | $26,818 | $766 |
| Androgel | 11 | $14,832 | $1,348 |
| Invokana | 20 | $13,084 | $654 |
| Januvia | 11 | $11,383 | $1,035 |
| Lantus Solostar | 28 | $11,293 | $403 |
| Spiriva | 20 | $10,166 | $508 |
| Crestor | 11 | $7,087 | $644 |
| Advair Diskus | 17 | $6,629 | $390 |
| Benicar | 11 | $3,682 | $335 |
| Atorvastatin | 146 | $3,519 | $24 |
| Morphine Sulfate Er | 27 | $3,246 | $120 |
| Symbicort | 11 | $3,077 | $280 |
| Flovent Hfa | 11 | $2,959 | $269 |
| Levothyroxine | 115 | $2,835 | $25 |
| Pataday | 17 | $2,735 | $161 |
| Tamsulosin | 43 | $2,285 | $53 |
| Celecoxib | 24 | $2,264 | $94 |
| Clonidine | 12 | $2,250 | $188 |
| Felodipine Er | 40 | $2,247 | $56 |
| Gabapentin | 57 | $1,955 | $34 |
| Isosorbide Dinitrate | 15 | $1,905 | $127 |
| Entacapone | 12 | $1,834 | $153 |
| Hydrocodone-Acetaminophen | 71 | $1,703 | $24 |
| Metoprolol | 63 | $1,582 | $25 |
| Amlodipine Besylate | 195 | $1,497 | $8 |
| Venlafaxine Hcl Er | 12 | $1,306 | $109 |
| Metformin | 105 | $1,100 | $10 |
| Pravastatin | 27 | $1,076 | $40 |
| Oxycodone | 18 | $1,070 | $59 |
| Ventolin Hfa | 17 | $1,060 | $62 |
| Valsartan | 28 | $1,054 | $38 |
| Allopurinol | 29 | $991 | $34 |
| Proair Hfa | 17 | $925 | $54 |
| Hydralazine | 29 | $890 | $31 |
| Hydrochlorothiazide | 101 | $810 | $8 |
| Quetiapine | 35 | $809 | $23 |
| Losartan | 97 | $780 | $8 |
| Lisinopril | 114 | $735 | $6 |
| Bd Ultra-Fine Pen Needle | 18 | $729 | $41 |
| Potassium Chloride | 26 | $728 | $28 |
| Escitalopram | 38 | $642 | $17 |
| Fluticasone Propionate | 53 | $584 | $11 |
| Carvedilol | 51 | $580 | $11 |
| Carbidopa-Levodopa Er | 14 | $573 | $41 |
| Donepezil | 16 | $567 | $35 |
| Voltaren | 11 | $546 | $50 |
| Simvastatin | 60 | $513 | $9 |
| Montelukast | 23 | $501 | $22 |
| Triamcinolone Acetonide | 23 | $498 | $22 |
| Azelastine | 11 | $435 | $40 |
| Lovastatin | 24 | $434 | $18 |
| Carbidopa-Levodopa | 12 | $423 | $35 |
| Bumetanide | 18 | $422 | $23 |
| Omeprazole | 32 | $404 | $13 |
| Ramipril | 33 | $401 | $12 |
| Clonidine | 12 | $283 | $24 |
| Zolpidem | 24 | $277 | $12 |
| Spironolactone | 20 | $258 | $13 |
| Pantoprazole | 15 | $252 | $17 |
| Clopidogrel | 18 | $221 | $12 |
| Glipizide Xl | 12 | $215 | $18 |
| Diazepam | 51 | $213 | $4 |
| Tramadol | 37 | $198 | $5 |
| Warfarin | 16 | $196 | $12 |
| Losartan-Hydrochlorothiazide | 18 | $191 | $11 |
| Furosemide | 34 | $182 | $5 |
| Alendronate | 17 | $140 | $8 |
| Alcohol Prep Pads | 11 | $137 | $12 |
| Meloxicam | 13 | $128 | $10 |
| Trazodone | 23 | $123 | $5 |
| Triamterene-Hydrochlorothiazid | 12 | $120 | $10 |
| Famotidine | 17 | $113 | $7 |
| Alprazolam | 30 | $98 | $3 |
| Prednisone | 14 | $87 | $6 |
| Citalopram Hbr | 12 | $77 | $6 |
| Metoprolol | 13 | $71 | $5 |
| Lorazepam | 11 | $63 | $6 |
| Atenolol | 14 | $56 | $4 |
| Nortriptyline | 11 | $49 | $4 |
2015: 85 drugs
| Lantus Solostar | 26 | $16,921 | $651 |
| Januvia | 24 | $13,027 | $543 |
| Androgel | 25 | $11,711 | $468 |
| Spiriva | 22 | $7,169 | $326 |
| Zetia | 24 | $7,058 | $294 |
| Aggrenox | 11 | $6,715 | $610 |
| Benicar | 16 | $5,812 | $363 |
| Invokana | 12 | $5,774 | $481 |
| Metformin Hcl Er | 18 | $4,956 | $275 |
| Atorvastatin | 233 | $4,783 | $21 |
| Tamsulosin | 72 | $4,507 | $63 |
| Advair Diskus | 16 | $4,345 | $272 |
| Lyrica | 13 | $3,960 | $305 |
| Jardiance | 11 | $3,810 | $346 |
| Morphine Sulfate Er | 24 | $3,651 | $152 |
| Levothyroxine | 143 | $3,641 | $25 |
| Metoprolol | 67 | $2,234 | $33 |
| Diltiazem 24hr Er | 24 | $2,205 | $92 |
| Duloxetine | 22 | $2,074 | $94 |
| Hydrocodone-Acetaminophen | 72 | $2,029 | $28 |
| Clonidine | 11 | $1,913 | $174 |
| Isosorbide Dinitrate | 19 | $1,786 | $94 |
| Amlodipine Besylate | 256 | $1,727 | $7 |
| Proair Hfa | 25 | $1,516 | $61 |
| Baclofen | 15 | $1,450 | $97 |
| Valsartan | 22 | $1,372 | $62 |
| Pravastatin | 42 | $1,340 | $32 |
| Metformin | 109 | $1,335 | $12 |
| Potassium Chloride | 35 | $1,205 | $34 |
| Oxycodone | 27 | $1,189 | $44 |
| Quetiapine | 40 | $1,180 | $30 |
| Gabapentin | 35 | $1,144 | $33 |
| Hydrochlorothiazide | 152 | $1,138 | $7 |
| Losartan | 84 | $1,018 | $12 |
| Ventolin Hfa | 11 | $1,013 | $92 |
| Allopurinol | 31 | $975 | $31 |
| Voltaren | 17 | $944 | $56 |
| Simvastatin | 89 | $890 | $10 |
| Fluticasone Propionate | 65 | $887 | $14 |
| Ramipril | 43 | $849 | $20 |
| Omeprazole | 64 | $772 | $12 |
| Carbidopa-Levodopa | 15 | $770 | $51 |
| Hydralazine | 21 | $738 | $35 |
| Bd Ultra-Fine Pen Needle | 19 | $738 | $39 |
| Triamcinolone Acetonide | 24 | $715 | $30 |
| Chlorthalidone | 13 | $693 | $53 |
| Clopidogrel | 28 | $691 | $25 |
| Felodipine Er | 12 | $639 | $53 |
| Pantoprazole | 30 | $634 | $21 |
| Lovastatin | 36 | $628 | $17 |
| Lisinopril | 98 | $626 | $6 |
| Bumetanide | 25 | $541 | $22 |
| Famotidine | 27 | $491 | $18 |
| Warfarin | 25 | $460 | $18 |
| Venlafaxine Hcl Er | 17 | $442 | $26 |
| Losartan-Hydrochlorothiazide | 13 | $432 | $33 |
| Carvedilol | 33 | $391 | $12 |
| Zolpidem | 36 | $385 | $11 |
| Montelukast | 15 | $377 | $25 |
| Enalapril Maleate | 18 | $368 | $20 |
| Klor-Con 10 | 11 | $346 | $31 |
| Glipizide | 21 | $324 | $15 |
| Doxazosin Mesylate | 11 | $307 | $28 |
| Furosemide | 39 | $297 | $8 |
| Tramadol | 47 | $275 | $6 |
| Finasteride | 19 | $259 | $14 |
| Meloxicam | 38 | $249 | $7 |
| Diazepam | 45 | $240 | $5 |
| Methimazole | 16 | $236 | $15 |
| Lorazepam | 19 | $219 | $12 |
| Metoprolol | 26 | $214 | $8 |
| Atenolol | 34 | $214 | $6 |
| Sertraline | 28 | $182 | $6 |
| Ibuprofen | 27 | $171 | $6 |
| Topiramate | 16 | $170 | $11 |
| Spironolactone | 16 | $169 | $11 |
| Ropinirole | 12 | $167 | $14 |
| Alendronate | 24 | $164 | $7 |
| Escitalopram | 19 | $161 | $8 |
| Temazepam | 20 | $156 | $8 |
| Trazodone | 16 | $142 | $9 |
| Alprazolam | 30 | $122 | $4 |
| Clonazepam | 21 | $115 | $5 |
| Naproxen | 16 | $102 | $6 |
| Citalopram Hbr | 25 | $84 | $3 |
2014: 108 drugs
| Januvia | 65 | $30,072 | $463 |
| Lantus Solostar | 44 | $18,644 | $424 |
| Crestor | 31 | $13,735 | $443 |
| Aggrenox | 20 | $8,892 | $445 |
| Namenda | 14 | $8,451 | $604 |
| Levemir Flexpen | 16 | $8,120 | $508 |
| Spiriva | 25 | $7,410 | $296 |
| Atorvastatin | 325 | $7,101 | $22 |
| Onglyza | 15 | $6,533 | $436 |
| Advair Diskus | 19 | $6,438 | $339 |
| Zetia | 28 | $6,367 | $227 |
| Androgel | 15 | $5,956 | $397 |
| Vesicare | 14 | $5,309 | $379 |
| Diovan | 18 | $5,244 | $291 |
| Clonidine | 23 | $5,005 | $218 |
| Lyrica | 15 | $4,903 | $327 |
| Niacin Er | 17 | $4,784 | $281 |
| Lantus | 11 | $4,039 | $367 |
| Morphine Sulfate Er | 19 | $3,706 | $195 |
| Colcrys | 17 | $3,696 | $217 |
| Metoprolol | 101 | $3,565 | $35 |
| Metformin Hcl Er | 33 | $3,475 | $105 |
| Levothyroxine | 187 | $3,437 | $18 |
| Opana Er | 12 | $3,203 | $267 |
| Amlodipine Besylate | 362 | $3,084 | $9 |
| Benicar | 12 | $3,004 | $250 |
| Gabapentin | 90 | $2,698 | $30 |
| Hydrocodone-Acetaminophen | 99 | $2,686 | $27 |
| Flovent Hfa | 13 | $2,653 | $204 |
| Ramipril | 112 | $2,518 | $22 |
| Tamsulosin | 83 | $2,449 | $30 |
| Duloxetine | 11 | $2,442 | $222 |
| Isosorbide Dinitrate | 18 | $2,338 | $130 |
| Metformin | 156 | $2,330 | $15 |
| Pravastatin | 84 | $2,252 | $27 |
| Fluticasone Propionate | 115 | $2,202 | $19 |
| Oxycodone | 26 | $2,154 | $83 |
| Proair Hfa | 38 | $1,967 | $52 |
| Baclofen | 35 | $1,917 | $55 |
| Losartan | 143 | $1,831 | $13 |
| Hydrochlorothiazide | 279 | $1,711 | $6 |
| Felodipine Er | 36 | $1,703 | $47 |
| Lansoprazole | 16 | $1,691 | $106 |
| Simvastatin | 136 | $1,586 | $12 |
| Lisinopril | 210 | $1,515 | $7 |
| Bystolic | 13 | $1,275 | $98 |
| Omeprazole | 75 | $1,151 | $15 |
| Labetalol | 18 | $1,146 | $64 |
| Fenofibrate | 15 | $1,044 | $70 |
| Nifedipine Er | 19 | $1,036 | $55 |
| Doxazosin Mesylate | 31 | $1,002 | $32 |
| Montelukast | 29 | $971 | $33 |
| Hydralazine | 28 | $952 | $34 |
| Chlorthalidone | 42 | $924 | $22 |
| Paroxetine | 22 | $924 | $42 |
| Lovastatin | 43 | $921 | $21 |
| Potassium Chloride | 22 | $873 | $40 |
| Allopurinol | 67 | $828 | $12 |
| Amantadine | 11 | $788 | $72 |
| Triamcinolone Acetonide | 30 | $776 | $26 |
| Bd Ultra-Fine Pen Needle | 17 | $760 | $45 |
| Alendronate | 46 | $700 | $15 |
| Voltaren | 12 | $691 | $58 |
| Clopidogrel | 23 | $686 | $30 |
| Carvedilol | 42 | $679 | $16 |
| Pantoprazole | 32 | $656 | $20 |
| Klor-Con 10 | 17 | $612 | $36 |
| Finasteride | 25 | $503 | $20 |
| Venlafaxine Hcl Er | 15 | $495 | $33 |
| Tramadol | 61 | $493 | $8 |
| Isosorbide Mononitrate Er | 12 | $466 | $39 |
| Metoprolol | 49 | $431 | $9 |
| Bumetanide | 20 | $412 | $21 |
| Bupropion Xl | 11 | $394 | $36 |
| Sertraline | 51 | $392 | $8 |
| Escitalopram | 30 | $382 | $13 |
| Furosemide | 59 | $346 | $6 |
| Carbidopa-Levodopa | 13 | $331 | $25 |
| Losartan-Hydrochlorothiazide | 13 | $322 | $25 |
| Quetiapine | 23 | $322 | $14 |
| Glipizide Er | 14 | $319 | $23 |
| Citalopram Hbr | 54 | $309 | $6 |
| Famotidine | 27 | $296 | $11 |
| Levetiracetam | 15 | $294 | $20 |
| Ropinirole | 25 | $283 | $11 |
| Diphenoxylate-Atropine | 15 | $283 | $19 |
| Atenolol | 51 | $280 | $5 |
| Topiramate | 16 | $267 | $17 |
| Diazepam | 46 | $266 | $6 |
| Buspirone | 13 | $247 | $19 |
| Latanoprost | 22 | $241 | $11 |
| Alprazolam | 51 | $240 | $5 |
| Zolpidem | 37 | $234 | $6 |
| Enalapril Maleate | 13 | $232 | $18 |
| Spironolactone | 20 | $225 | $11 |
| Meloxicam | 26 | $212 | $8 |
| Ibuprofen | 35 | $197 | $6 |
| Warfarin | 15 | $191 | $13 |
| Donepezil | 15 | $179 | $12 |
| Prednisone | 12 | $178 | $15 |
| Glipizide Xl | 15 | $169 | $11 |
| Trazodone | 28 | $168 | $6 |
| Glipizide | 12 | $141 | $12 |
| Nortriptyline | 12 | $140 | $12 |
| Benazepril | 12 | $111 | $9 |
| Clonazepam | 13 | $78 | $6 |
| Acyclovir | 15 | $77 | $5 |
| Temazepam | 12 | $74 | $6 |
2013: 106 drugs
| Januvia | 72 | $25,975 | $361 |
| Crestor | 44 | $15,259 | $347 |
| Advair Diskus | 30 | $9,996 | $333 |
| Atorvastatin | 285 | $9,049 | $32 |
| Lantus Solostar | 24 | $8,575 | $357 |
| Aggrenox | 25 | $8,313 | $333 |
| Spiriva | 23 | $6,376 | $277 |
| Cymbalta | 25 | $6,240 | $250 |
| Niaspan | 13 | $6,218 | $478 |
| Levemir Flexpen | 21 | $6,143 | $293 |
| Diovan | 23 | $6,065 | $264 |
| Androgel | 15 | $5,406 | $360 |
| Onglyza | 21 | $5,232 | $249 |
| Lyrica | 14 | $4,824 | $345 |
| Clonidine | 12 | $4,618 | $385 |
| Zetia | 18 | $4,124 | $229 |
| Colcrys | 15 | $4,029 | $269 |
| Vesicare | 15 | $4,016 | $268 |
| Gabapentin | 86 | $3,808 | $44 |
| Amlodipine Besylate | 317 | $3,445 | $11 |
| Premarin | 12 | $3,415 | $285 |
| Lantus | 14 | $3,075 | $220 |
| Celebrex | 12 | $2,955 | $246 |
| Benicar | 14 | $2,953 | $211 |
| Humalog | 11 | $2,912 | $265 |
| Felodipine Er | 42 | $2,769 | $66 |
| Metoprolol | 77 | $2,698 | $35 |
| Flovent Hfa | 14 | $2,612 | $187 |
| Metformin | 158 | $2,509 | $16 |
| Fluticasone Propionate | 80 | $2,216 | $28 |
| Hydrocodone-Acetaminophen | 109 | $2,132 | $20 |
| Proair Hfa | 38 | $1,982 | $52 |
| Morphine Sulfate Er | 26 | $1,968 | $76 |
| Tamsulosin | 74 | $1,963 | $27 |
| Paroxetine | 32 | $1,938 | $61 |
| Losartan | 129 | $1,864 | $14 |
| Lisinopril | 238 | $1,849 | $8 |
| Ramipril | 91 | $1,813 | $20 |
| Levothyroxine | 159 | $1,741 | $11 |
| Hydrochlorothiazide | 257 | $1,684 | $7 |
| Simvastatin | 162 | $1,621 | $10 |
| Doxycycline Hyclate | 15 | $1,616 | $108 |
| Nifedipine Er | 22 | $1,589 | $72 |
| Montelukast | 34 | $1,524 | $45 |
| Lovastatin | 55 | $1,235 | $22 |
| Valsartan-Hydrochlorothiazide | 16 | $1,180 | $74 |
| Omeprazole | 57 | $1,178 | $21 |
| Metronidazole | 13 | $1,149 | $88 |
| Oxycodone | 30 | $1,147 | $38 |
| Pravastatin | 51 | $1,119 | $22 |
| Labetalol | 24 | $1,004 | $42 |
| Triamcinolone Acetonide | 35 | $919 | $26 |
| Bystolic | 12 | $898 | $75 |
| Hydralazine | 21 | $896 | $43 |
| Chlorthalidone | 46 | $872 | $19 |
| Potassium Chloride | 26 | $865 | $33 |
| Clopidogrel | 40 | $854 | $21 |
| Bupropion Hcl Sr | 12 | $838 | $70 |
| Baclofen | 28 | $776 | $28 |
| Escitalopram | 17 | $765 | $45 |
| Ropinirole | 35 | $739 | $21 |
| Tramadol | 72 | $706 | $10 |
| Bd Ultra-Fine Pen Needle | 15 | $685 | $46 |
| Alendronate | 34 | $671 | $20 |
| Warfarin | 41 | $627 | $15 |
| Pantoprazole | 30 | $607 | $20 |
| Carvedilol | 34 | $604 | $18 |
| Spironolactone | 38 | $601 | $16 |
| Glipizide Er | 32 | $538 | $17 |
| Allopurinol | 46 | $534 | $12 |
| Diltiazem 24hr Er | 12 | $528 | $44 |
| Sertraline | 50 | $525 | $10 |
| Klor-Con 10 | 18 | $512 | $28 |
| Naltrexone | 11 | $482 | $44 |
| Finasteride | 22 | $465 | $21 |
| Losartan-Hydrochlorothiazide | 14 | $448 | $32 |
| Citalopram Hbr | 44 | $421 | $10 |
| Isosorbide Mononitrate Er | 15 | $417 | $28 |
| Carbidopa-Levodopa | 12 | $384 | $32 |
| Quetiapine | 25 | $379 | $15 |
| Glyburide | 14 | $369 | $26 |
| Doxazosin Mesylate | 16 | $368 | $23 |
| Lithium Carbonate | 12 | $310 | $26 |
| Clonidine | 14 | $283 | $20 |
| Donepezil | 14 | $272 | $19 |
| Atenolol | 46 | $270 | $6 |
| Metoprolol | 29 | $265 | $9 |
| Buspirone | 16 | $248 | $15 |
| Prednisone | 27 | $242 | $9 |
| Zolpidem | 39 | $240 | $6 |
| Alprazolam | 42 | $216 | $5 |
| Trazodone | 29 | $212 | $7 |
| Diazepam | 41 | $198 | $5 |
| Furosemide | 46 | $195 | $4 |
| Triamterene-Hydrochlorothiazid | 12 | $177 | $15 |
| Nortriptyline | 14 | $161 | $12 |
| Klor-Con 8 | 11 | $159 | $14 |
| Ibuprofen | 31 | $146 | $5 |
| Ranitidine | 12 | $138 | $11 |
| Benazepril | 16 | $137 | $9 |
| Bumetanide | 18 | $129 | $7 |
| Fluoxetine | 12 | $121 | $10 |
| Clonazepam | 14 | $110 | $8 |
| Propranolol | 14 | $92 | $7 |
| Lamotrigine | 11 | $66 | $6 |
| Captopril | 11 | $64 | $6 |
Money from drug and device companies
$15 in 2024
| 2024 | 1 | 1 | None | $15 |
| 2022 | 2 | 2 | None | $44 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Ligasure | $15 | 1 payment
|
See the published payment
| Medtronic | Meals · 2024-09-24 | Ligasure | $15 |
See earlier years (2022)
2022: $44
| Sanofi Pasteur | Flublok Quadrivalent Northern Hemisphere | $26 | 1 payment
|
| Hologic | Aptima | $17 | 1 payment
|
Professional record
- NPI
- 1811956469
- Licence
- CA G74264California G74264: Current · expires 2028-03-31
- Trained
- University of California, San Diego School of Medicine, 1989
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 11875 Dublin Blvd, Suite C 140, Dublin, CA, 94568
- NPI first listed
- 2006-03-22
- NPI last updated
- 2024-04-29
- NPI record certified
- 2024-04-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Palo Alto, CA, 94304